Recommendation of using systemic anti-tumor necrosis factor-alpha for the treatment of noninfectious uveitis in Taiwan

DOI: 10.4103/tjo.tjo_32_18

Keywords: Adalimumab, immunomodulatory, noninfectious, treatment, tumor necrosis factor, uveitis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text